Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Follicle Stimulating Hormone Sector?

In the past few years, an unwavering expansion has been witnessed in the follicle stimulating hormone (FSH) market size. The market is projected to rise from its 2024 value of $2.03 billion to $2.12 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. The previous period’s growth is linked to multiple factors, such as the escalating number of hormonal disorder cases, the surging requirement for fertility treatments, broadening of FSH applications, introduction of new FSH products in the market, and increasing demand for reliable and effective contraceptive methods.

Forecasts project significant expansion in the follicle stimulating hormone market size over the coming years. The market is predicted to reach a value of $2.59 billion by 2029, fueled by a compound annual growth rate (CAGR) of 5.2%. Factors contributing to the projected growth in the forecast period include a broader range of therapeutic applications, an increasing demand for combination therapy, a greater requirement for effective contraceptive solutions, the healthcare needs of an aging population, and market growth in key areas. The period is also expected to see key trends such as improved biosimilar FSH products, regulatory authorization and market access, technological progress in FSH production and delivery, and a heightened need for effective contraceptive options.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp

What Forces Are Driving The Growth Of The Follicle Stimulating Hormone Market?

Escalating rates of infertility are set to stimulate growth in the follicle-stimulating hormone market. Characterized by the inability in a male or female reproductive system to conceive after at least 12 months of regular, unprotected sexual contacts, infertility is becoming more common. The follicle-stimulating hormone plays a critical role in promoting the maturation of eggs in ovaries and maintaining regular menstruation cycles in women. In men, it fosters testicular development and production of a vital protein for male fertility by facilitating the growth of healthy sperm cells. For instance, the World Health Organization, a UN Representative in Switzerland, reported in April 2023 that about one in 6 adults globally, or around 17.5% of the adult population, suffered from infertility. Further, data from the Australian Bureau of Statistics, a self-ruling constitutional body in Australia, indicated in October 2023 that births recorded in 2022 were 300,684, witnessing a 3% decline from 2021. The general fertility rate for all Australian women stood at 1.63 births each woman. Consequently, the growing frequency of infertility is driving growth in the follicle-stimulating hormone market.

How Is The Follicle Stimulating Hormone Industry Segmented Across Key Parameters?

The follicle stimulating hormone market covered in this report is segmented –

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

Subsegments:

1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations

2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones

What Notable Trends Are Shaping The Direction Of The Follicle Stimulating Hormone Market?

A rising trend being observed in the follicle-stimulating hormone market revolves around product innovations. Prominent companies within the market are putting their efforts on crafting novel products to solidify their market presence. One such example is Proov, a US-based enterprise that focuses on women’s health, which introduced the Proov Empower Perimenopause Testing System in July 2024. This system delivers an extensive and personalized interpretation of a woman’s fluctuating hormones and their impact on her health and wellness. As a non-invasive urinary test that can be taken at numerous times, it measures four critical hormones – FSH, the estrogen marker E1G, the progesterone marker PdG, and LH – all of which play a role in symptoms and the experience of perimenopause. With the possibility of regular retesting, Proov Empower enables women to monitor hormone variations and symptoms, acting as a beneficial guide throughout the menopause transition.

Which Companies Currently Dominate The Competitive Landscape In The Follicle Stimulating Hormone Industry?

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem’s life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

Which Geographic Regions Are Driving Demand In The Follicle Stimulating Hormone Market?

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12486&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model